UBS Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-130,654
| Closed | -$12.7M | – | 7424 |
|
|
2019
Q3 | $12.7M | Buy |
130,654
+96,679
| +285% | +$9.38M | ﹤0.01% | 1239 |
|
|
2019
Q2 | $3.48M | Sell |
33,975
-62,082
| -65% | -$6.36M | ﹤0.01% | 2079 |
|
|
2019
Q1 | $10.9M | Buy |
96,057
+87,903
| +1,078% | +$10M | ﹤0.01% | 1303 |
|
|
2018
Q4 | $319K | Sell |
8,154
-1,165
| -13% | -$45.6K | ﹤0.01% | 3787 |
|
|
2018
Q3 | $508K | Sell |
9,319
-3,511
| -27% | -$191K | ﹤0.01% | 3621 |
|
|
2018
Q2 | $1.06M | Sell |
12,830
-99,594
| -89% | -$8.24M | ﹤0.01% | 3026 |
|
|
2018
Q1 | $7.49M | Buy |
112,424
+58,069
| +107% | +$3.87M | ﹤0.01% | 1551 |
|
|
2017
Q4 | $2.8M | Sell |
54,355
-23,046
| -30% | -$1.19M | ﹤0.01% | 2270 |
|
|
2017
Q3 | $6.9M | Buy |
77,401
+58,545
| +310% | +$5.22M | ﹤0.01% | 1496 |
|
|
2017
Q2 | $1.13M | Buy |
18,856
+14,832
| +369% | +$886K | ﹤0.01% | 2823 |
|
|
2017
Q1 | $215K | Sell |
4,024
-39,954
| -91% | -$2.13M | ﹤0.01% | 3785 |
|
|
2016
Q4 | $2.19M | Buy |
43,978
+34,317
| +355% | +$1.71M | ﹤0.01% | 2222 |
|
|
2016
Q3 | $580K | Buy |
9,661
+2,237
| +30% | +$134K | ﹤0.01% | 3066 |
|
|
2016
Q2 | $380K | Sell |
7,424
-11,384
| -61% | -$583K | ﹤0.01% | 3344 |
|
|
2016
Q1 | $555K | Sell |
18,808
-17,488
| -48% | -$516K | ﹤0.01% | 3049 |
|
|
2015
Q4 | $1.65M | Buy |
36,296
+30,403
| +516% | +$1.38M | ﹤0.01% | 2336 |
|
|
2015
Q3 | $246K | Buy |
5,893
+5,693
| +2,847% | +$238K | ﹤0.01% | 3569 |
|
|
2015
Q2 | $12K | Sell |
200
-851
| -81% | -$51.1K | ﹤0.01% | 5890 |
|
|
2015
Q1 | $82K | Buy |
+1,051
| New | +$82K | ﹤0.01% | 4309 |
|